$CNAT Will Continue to Surge Higher? – Tale of the Tape

0
600
Biotech Stocks

Will Conatus Pharmaceuticals (CNAT) Continue to Surge Higher? – Tale of the Tape

Conatus Pharmaceuticals Inc (CNAT)has been on the move lately as the stock has risen by 19.9% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?

While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on CNAT is moving in the right direction. In fact, the stock currently has a Zacks Rank #2 (Buy), suggesting that the recent run could certainly continue for this in-focus company.

LEAVE A REPLY

Please enter your comment!
Please enter your name here